DJIA 17,630.27 0.00 0.00%
NASDAQ 5,089.21 0.00 0.00%
S&P 500 2,093.25 0.00 0.00%
market minute promo

GlaxoSmithKline (NYSE: GSK)

42.82 1.11 (2.66%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

GSK $42.81 2.64%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.45
Previous Close $41.71
Daily Range $41.25 - $41.77
52-Week Range $41.19 - $49.24
Market Cap $103.4B
P/E Ratio 14.30
Dividend (Yield) $2.34 (6.1%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,906,742
Average Daily Volume 3,898,858
Current FY EPS $2.44




Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website:

News & Commentary

3 Questions GlaxoSmithKline Investors Want Answered on July 29

Pharmaceutical giant GlaxoSmithKline is slated to report its second-quarter results on July 29. Here are three questions investors want answered in Glaxo's report.

Glaxo (GSK) Beats on Q2 Earnings, Revenues Up Y/Y - Tale of the Tape

GlaxoSmithKline (GSK) Is Today's Pre-Market Mover With Heavy Volume Stock

Pre-Market Most Active for Jul 29, 2015 : CFG, TWTR, GSK, SIRI, YELP, FB, FCAU, STO, GILD, QQQ, BLD

Pre-Market Most Active for Jul 29, 2015 : CFG, TWTR, GSK, SIRI, YELP, FB, FCAU, STO, GILD, QQQ, BLDR, AAPL

ISIS Pharmaceuticals: Another Entry Point

NantKwest Inc.: Our IPO Pick Of The Week

Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog

HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opportunity

The Importance Of Newly-Released Data For Gilead's HIV Drug Patent Cliff

Perrigo (PRGO) to Buy Yokebe Brand; Boost EU Presence - Analyst Blog

See More GSK News...

GSK's Top Competitors

GSK $42.82 (2.66%)
Current stock: GSK
JNJ $99.18 (0.16%)
Current stock: JNJ
NVS $103.66 (0.85%)
Current stock: NVS
RHHBY $36.18 (0.30%)
Current stock: RHHBY